Deutsche Supports Mallinckrodt/Sun Acquisition Merger
Mallinckrodt entered into an agreement to merge Sun Acquisition and Sucampo Pharmaceuticals. Deutsche Bank agented a $900 million revolving credit facility to support the transaction.
January 15, 2018
Mallinckrodt | Sucampo Pharmaceuticals | Sun Acquisition
ABF Journal